Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.

Acta Oncologica

Volumn 47, Issue 4, 2008, Pages 682-690

  Ewertz, Marianne ^a   Moe Kempel, Mette ^b   Düring, Maria ^c   Jensen, Maj Britt ^c   Andersson, Michael ^d   Christiansen, Peer ^e   Kroman, Niels ^c   Bruun Rasmussen, Birgitte ^f   Overgaard, Marie ^e  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d FINSEN LABORATORY   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; MEGESTROL ACETATE; METHOTREXATE; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DATA BASE; DENMARK; EVALUATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; TUMOR VOLUME; BREAST TUMOR; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL RATE;

EID: 45149132256     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802032769     Document Type: Article

References (22)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery on early breast cancer. An overview of the randomized trials. N Engl J Med 1995;333:1444-55.
2. Blichert-Toft M, Düring M, Møller S, Nielsen M, Rank F, Overgaard M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008;47:672-81.
3. Andersen KW, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988;27:627-47.
4. Histological Typing of Breast Tumours, 2nd ed. International histological classification of tumour. Geneva: World Health Organisation; 1981.
5. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histologicalgrade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
6. Ejlertsen B, Mouridsen HT, Jensen MB, Bengtsson NO, Bergh J, Cold S, et al. Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluouracil: From a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer. J Clin Oncol 2006;24:4956-62.
7. Andersen J, Nielsen DL, Ejlertsen B, Cold S, Ewertz M, Jacobsen EJ, et al. DBCG study 89C: A randomised phase III trial of adjuvant endocrine therapy with tamoxifen for one year vs. tamoxifen for two years vs. tamoxifen for 6 months followed by megestrol acetate for 6 months in postmenopausal high risk patients with steroid receptor-positive og - unknown breast cancer. Acta Oncol 2008;47:718-24.
8. Ejlertsen B, Mouridsen HT, Jensen MB, Andersen J, Jensen BB, Cold S, et al. Improved outcome from substituting methotrexate with epirubicin: Results from a randomized comparison of CMF versus CEF in patients with primary breast cancer. Eur J Cancer 2007;43:877-84.
9. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
10. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and on 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-106.
11. Harrold EV, Turner BC, Matloff ET, Pathare P, Beinfield M, McKahnn C, et al. Local recurrence in the conservatively treated breast cancer patient: A correlation with age and family history. Cancer J Sci Am 1998;4:302-7.
12. Elkhuisen PH, Voogd AC, van den Broek LC, Tan IT, van Houwelingen HC, Leer JW, et al. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys 1999;45:73-83.
13. Touboul E, Buffat L, Belmacemi Y, LeFranc JP, Uzan S, Lhuillier P, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999;43:25-38.
14. Bartelink H, Horiot J-C, Poortmans P, Stuikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345:1378-87.
15. Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary E, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002;9:256-65.
16. Perez CA. Conservation therapy in T1-T2 breast cancer: Past, current issues and future challenges and opportunities. Cancer J 2003;9:442-53.
17. Kroman N, Holtveg H, Wohlfahrt J, Jensen M, Mouridsen HT, Blicher-Toft M, et al. Effect of breast conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 2004;100:68.
18. Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-15.
19. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;8:1668-75.
20. McIntosh A, Freedman G, Eisenberg D, Anderson P. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am J Clin Oncol 2007;2:146-51.
21. Chism DB, Freedman GM, Li T, Anderson PR. Re-excision of margins before breast radiation-diagnostic or therapeutic? Int J Radiat Oncol Biol Phys 2006;65:1416-21.
22. Cronin-Fenton DP, Nørgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, et al. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 2007;96:1462-8.